Edward Stelmakh

Insider Reports History

Entity
Individual
Location
400 Water Street, Suite 200, Rochester, MI
Signature
/s/ Marion Odence-Ford, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Edward Stelmakh:

Stock Role Class Num Shares Value Price $ Report Date Ownership
OptimizeRx Corp CFO/COO Common Stock 14.8K $236K $15.95 Feb 15, 2024 Direct
OptimizeRx Corp CFO/COO Restricted Stock Units 8.22K $125K $15.19 Oct 11, 2023 Direct
OptimizeRx Corp CFO/COO Stock Option 15.7K $118K $7.51 Dec 19, 0023 Direct
OptimizeRx Corp CFO/COO Common 28K Oct 11, 2023 Direct

Insider Reports Filed by Edward Stelmakh

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OPRX OptimizeRx Corp Feb 15, 2024 1 $0 4 Apr 24, 2024 CFO/COO
OPRX OptimizeRx Corp Oct 11, 2023 1 $0 4/A Apr 22, 2024 CFO/COO
OPRX OptimizeRx Corp Oct 3, 2023 3 -$29.1K 4 Oct 6, 2023 CFO/COO
OPRX OptimizeRx Corp Oct 11, 2022 1 -$53.7K 4/A Apr 22, 2024 CFO/COO
OPRX OptimizeRx Corp Oct 11, 2022 5 -$14.8K 4 Oct 12, 2023 CFO/COO
OPRX OptimizeRx Corp Oct 11, 2022 3 -$99.2K 4 Mar 30, 2023 CFO/COO
OPRX OptimizeRx Corp Oct 3, 2022 2 $0 4 Oct 5, 2022 CFO/COO
OPRX OptimizeRx Corp Aug 15, 2022 1 $46.3K 4 Aug 17, 2022 CFO/COO
OPRX OptimizeRx Corp Oct 11, 2021 2 $0 4 Oct 13, 2021 COO and CFO
OPRX OptimizeRx Corp Oct 11, 2021 0 $0 3 Oct 12, 2021 COO and CFO
OPRX OptimizeRx Corp Dec 19, 0023 2 $0 4 Feb 21, 2024 CFO/COO